JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.77B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$5.31B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.14B |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.76B |
| 5 |
Apple
AAPL
|
+$2.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.22B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.77B |
| 3 |
Nike
NKE
|
+$744M |
| 4 |
Schwab US TIPS ETF
SCHP
|
+$710M |
| 5 |
Truist Financial
TFC
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Healthcare | 10.48% |
| 3 | Financials | 8.96% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Industrials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Home BancShares
HOMB
$6.3B
| $26.3M | ﹤0.01% |
1,154,351
-90,130
| -7% | -$1.97M |
|
1477
Health Catalyst
HCAT
$160M
| $26.3M | ﹤0.01% |
2,105,124
+242,609
| +13% | +$2.89M |
|
1478
Kulicke & Soffa
KLIC
$4.34B
| $26.2M | ﹤0.01% |
441,522
-41,123
| -9% | -$2.12M |
|
1479
PUT
Thermo Fisher Scientific
TMO
$214B
| $26.1M | ﹤0.01% |
50,000
-8,000
| -14% | -$4.32M |
|
1480
Schwab US Large- Cap ETF
SCHX
$70.3B
| $26.1M | ﹤0.01% |
1,492,617
-11,586
| -0.8% | -$191K |
|
1481
PUT
Prudential Financial
PRU
$42.6B
| $26M | ﹤0.01% |
295,000
-36,900
| -11% | -$3.09M |
|
1482
Tenet Healthcare
THC
$22.2B
| $25.9M | ﹤0.01% |
318,316
+49,265
| +18% | +$3.51M |
|
1483
Reinsurance Group of America
RGA
$15.5B
| $25.9M | ﹤0.01% |
186,738
+14,433
| +8% | +$2.05M |
|
1484
HEICO Corp
HEI
$49.6B
| $25.9M | ﹤0.01% |
146,278
+10,508
| +8% | +$1.77M |
|
1485
Silicon Laboratories
SLAB
$7.14B
| $25.9M | ﹤0.01% |
163,931
-135,804
| -45% | -$20.5M |
|
1486
Cabot Corp
CBT
$4.72B
| $25.8M | ﹤0.01% |
385,915
+27,970
| +8% | +$1.99M |
|
1487
Essential Properties Realty Trust
EPRT
$6.92B
| $25.8M | ﹤0.01% |
1,094,786
+225,917
| +26% | +$5.5M |
|
1488
Teleflex
TFX
$5.96B
| $25.7M | ﹤0.01% |
106,324
+11,322
| +12% | +$2.84M |
|
1489
Wyndham Hotels & Resorts
WH
$5.61B
| $25.7M | ﹤0.01% |
374,476
+43,814
| +13% | +$2.99M |
|
1490
Saic
SAIC
$4.95B
| $25.7M | ﹤0.01% |
228,243
+51,564
| +29% | +$5.36M |
|
1491
Vericel Corp
VCEL
$2.38B
| $25.6M | ﹤0.01% |
682,686
+26,172
| +4% | +$860K |
|
1492
NGL Energy Partners
NGL
$1.94B
| $25.6M | ﹤0.01% |
6,593,374
+840,125
| +15% | +$2.72M |
|
1493
Unitil
UTL
$989M
| $25.6M | ﹤0.01% |
504,659
+151,757
| +43% | +$8.42M |
|
|
JUSA
1494
DELISTED
JPMorgan ActiveBuilders U.S. Large Cap Equity ETF
JUSA
| $25.6M | ﹤0.01% |
504,655
-188
| -0% | -$8.98K |
|
1495
Interparfums
IPAR
$4.07B
| $25.5M | ﹤0.01% |
188,783
-19,223
| -9% | -$2.69M |
|
1496
NiSource
NI
$21.5B
| $25.5M | ﹤0.01% |
933,420
-41,323
| -4% | -$1.15M |
|
1497
PMV Pharmaceuticals
PMVP
$57.1M
| $25.5M | ﹤0.01% |
4,075,504
+72,620
| +2% | +$381K |
|
1498
Vanguard Mid-Cap Growth ETF
VOT
$18.9B
| $25.5M | ﹤0.01% |
123,721
-3,995
| -3% | -$774K |
|
1499
Gogo Inc
GOGO
$525M
| $25.4M | ﹤0.01% |
1,495,265
+646,921
| +76% | +$9.56M |
|
|
CEQP
1500
DELISTED
Crestwood Equity Partners LP
CEQP
| $25.4M | ﹤0.01% |
959,727
-319,498
| -25% | -$8.11M |
|
Similar funds
JP Morgan Chase's Q2 2023 Portfolio in Review
As of Q2 2023, JP Morgan Chase held 7,602 positions worth $920B, up 12% from $821B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $40.5B of net new capital in Q2 2023, opening 674 new positions and adding to 3,069 existing holdings. Its largest new stake was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $3.22B trimmed.
- JP Morgan Chase's largest Q2 2023 buy was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
- JP Morgan Chase added most to Microsoft in Q2 2023, an estimated $5.77B increase.
- JP Morgan Chase's biggest Q2 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $3.22B.
- JP Morgan Chase fully exited DCP Midstream, LP in Q2 2023, selling an estimated $328M.
- JP Morgan Chase's ten largest holdings make up 20% of its $920B portfolio in Q2 2023.
- JP Morgan Chase opened 674 new positions and closed 737 in Q2 2023.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $920B.
Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.